Biophytis S.A. (BPTSY)
OTCMKTS
· Delayed Price · Currency is USD
3.200
+0.150 (4.92%)
Dec 26, 2024, 11:09 AM EST
Biophytis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Selling, General & Admin | 5.01 | 5.49 | 7.24 | 7.15 | 4.02 | 6.59 | Upgrade
|
| Research & Development | 7.19 | 8.85 | 16.03 | 19.67 | 9.92 | 9.09 | Upgrade
|
| Operating Expenses | 12.2 | 14.33 | 23.27 | 26.82 | 13.94 | 15.68 | Upgrade
|
| Operating Income | -12.2 | -14.33 | -23.27 | -26.82 | -13.94 | -15.68 | Upgrade
|
| Interest Expense | -1.49 | -1.42 | -2.42 | -0.67 | -1.27 | -1.45 | Upgrade
|
| Interest & Investment Income | - | - | 0.99 | 0.02 | 0.03 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.1 | 0.04 | -0.03 | 0.01 | -0.03 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.08 | -1.31 | 0.59 | -2.02 | -10.31 | -1.91 | Upgrade
|
| EBT Excluding Unusual Items | -15.67 | -17.03 | -24.14 | -29.47 | -25.52 | -19.03 | Upgrade
|
| Legal Settlements | - | - | -0.08 | -1.7 | - | - | Upgrade
|
| Pretax Income | -15.08 | -17.03 | -24.22 | -31.16 | -25.52 | -19.03 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -0.08 | Upgrade
|
| Earnings From Continuing Operations | -15.08 | -17.03 | -24.22 | -31.16 | -25.52 | -18.95 | Upgrade
|
| Minority Interest in Earnings | 0.01 | - | - | 0 | - | - | Upgrade
|
| Net Income | -15.07 | -17.03 | -24.22 | -31.16 | -25.52 | -18.95 | Upgrade
|
| Net Income to Common | -15.07 | -17.03 | -24.22 | -31.16 | -25.52 | -18.95 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 307.72% | 210.61% | 47.81% | 97.22% | 255.24% | 26.23% | Upgrade
|
| EPS (Basic) | -5.59 | -12.54 | -55.40 | -105.38 | -170.19 | -448.88 | Upgrade
|
| EPS (Diluted) | -5.59 | -12.54 | -56.00 | -105.38 | -172.00 | -448.88 | Upgrade
|
| Free Cash Flow | -10.8 | -13.09 | -19.13 | -24.14 | -9.96 | -15.33 | Upgrade
|
| Free Cash Flow Per Share | -4.00 | -9.64 | -43.76 | -81.63 | -66.41 | -363.28 | Upgrade
|
| EBITDA | -11.8 | -13.8 | -23.04 | -26.5 | -13.66 | -15.42 | Upgrade
|
| D&A For EBITDA | 0.4 | 0.53 | 0.23 | 0.31 | 0.28 | 0.26 | Upgrade
|
| EBIT | -12.2 | -14.33 | -23.27 | -26.82 | -13.94 | -15.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.